Skip to main content
HLB bioStep Co.,Ltd. logo

HLB bioStep Co.,Ltd. — Investor Relations & Filings

Ticker · 278650 ISIN · KR7278650007 KO Professional, scientific and technical activities
Open in API
Filings indexed 326 across all filing types
Latest filing 2021-09-30 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 278650

About HLB bioStep Co.,Ltd.

http://hlbbiostep.com/en/

HLB bioStep Co.,Ltd. is a non-clinical Contract Research Organization (CRO) that provides a range of testing services to pharmaceutical companies and bio ventures. The company's core services support new drug development and include efficacy testing, pharmacokinetic/toxicokinetic (PK/TK) studies, and toxicology evaluations. A key area of specialization is veterinary medicine; HLB bioStep is an institution approved to conduct non-clinical tests and clinical trials for veterinary drugs. It also offers consulting services for regulatory approval procedures. The company utilizes various platform technologies, such as cell-enzyme-based screening and xenograft assays, and provides a comprehensive 'One-Stop Service' that leverages its experience in building laboratory facilities.

Recent filings

Filing Released Lang Actions
[기재정정]신규시설투자등
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (Notus) regarding a 'Correction Report' (정정신고) for a 'New Facility Investment' (신규시설투자). It details changes to the investment completion date and provides updated investment parameters. Since this is a specific regulatory disclosure regarding capital expenditure and facility investment updates that does not fit into the other specialized categories like M&A or Share Issues, it is classified as a general Regulatory Filing (RNS).
2021-09-30 Korean
자기주식처분결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a '자기주식처분결과보고서' (Report on the Results of Disposal of Treasury Shares) filed with the Financial Supervisory Service (FSS) in South Korea. It details the specific quantity, price, and counterparty involved in the company's disposal of its own shares. This falls under the category of 'Transaction in Own Shares' (POS).
2021-09-29 Korean
주요사항보고서(자기주식취득신탁계약해지결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from a Korean company (Knotus) regarding the termination of a share repurchase trust agreement (자기주식취득 신탁계약 해지 결정). This type of filing relates to the company's capital structure and treasury share management. Under the provided definitions, 'POS' (Transaction in Own Shares) is the most accurate category as it covers share buybacks and related trust contract activities.
2021-09-28 Korean
[기재정정]주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a 'Decision to Dispose of Treasury Shares' (자기주식 처분 결정) filed by Knotus Co., Ltd. It details changes to the disposal method (from block trade to off-exchange) and the disposal period. This falls under the category of a company reporting the sale or disposal of its own shares, which is classified as 'Transaction in Own Shares'.
2021-09-28 Korean
신탁계약해지결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on the Termination of a Trust Agreement' (신탁계약해지결과보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details the termination of a share repurchase trust contract (자기주식 신탁계약) and the resulting status of treasury shares. Since this document reports on the company's activity regarding its own shares (share buyback/termination of trust), it falls under the category of 'Transaction in Own Shares' (POS).
2021-09-28 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from a Korean company, Knotus, specifically detailing a 'Decision to Dispose of Treasury Shares' (자기주식 처분 결정). This document outlines the number of shares, price, purpose (cooperation), and method (block deal) of the share disposal. According to the provided filing definitions, the category 'Transaction in Own Shares' (POS) is specifically for reports of a company buying back or selling its own shares.
2021-09-27 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.